Clinical Trial Update: PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial of PNEUMOCELL, a conjugated pneumococcal vaccine, in patients with IgG deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogammaglobulinemia

Drugs mentioned

• PNEUMOCELL (Conjugated pneumococcal vaccine)

Snippet

Sponsor: Karolinska University Hospital | Conditions: IgG Deficiency | Phase 2 | Status: COMPLETED